Organ-specific manifestations of COVID-19 infection von Gavriatopoulou, Maria, Korompoki, Eleni, Fotiou, Despina, Ntanasis-Stathopoulos, Ioannis, Psaltopoulou, Theodora, Kastritis, Efstathios, Terpos, Evangelos, Dimopoulos, Meletios A.

Volltext

Emerging treatment strategies for COVID-19 infection von Gavriatopoulou, Maria, Ntanasis-Stathopoulos, Ioannis, Korompoki, Eleni, Fotiou, Despina, Migkou, Magdalini, Tzanninis, Ioannis-Georgios, Psaltopoulou, Theodora, Kastritis, Efstathios, Terpos, Evangelos, Dimopoulos, Meletios A.

Volltext

The neutralizing antibody response post COVID-19 vaccination in patients with myeloma is highly dependent on the type of anti-myeloma treatment von Terpos, Evangelos, Gavriatopoulou, Maria, Ntanasis-Stathopoulos, Ioannis, Briasoulis, Alexandros, Gumeni, Sentiljana, Malandrakis, Panagiotis, Fotiou, Despina, Papanagnou, Eleni-Dimitra, Migkou, Magdalini, Theodorakakou, Foteini, Roussou, Maria, Eleutherakis-Papaiakovou, Evangelos, Kanellias, Nikolaos, Trougakos, Ioannis P., Kastritis, Efstathios, Dimopoulos, Meletios A.

Volltext

Multiple Myeloma and Thrombosis: Prophylaxis and Risk Prediction Tools von Fotiou, Despina, Gavriatopoulou, Maria, Terpos, Evangelos

Volltext

Biomarkers in AL Amyloidosis von Fotiou, Despina, Theodorakakou, Foteini, Kastritis, Efstathios

Volltext

Systemic AL Amyloidosis: Current Approaches to Diagnosis and Management von Fotiou, Despina, Dimopoulos, Meletios Athanasios, Kastritis, Efstathios

Volltext

Carfilzomib-induced endothelial dysfunction, recovery of proteasome activity, and prediction of cardiovascular complications: a prospective study von Kastritis, Efstathios, Laina, Ageliki, Georgiopoulos, Georgios, Gavriatopoulou, Maria, Papanagnou, Eleni-Dimitra, Eleutherakis-Papaiakovou, Evangelos, Fotiou, Despina, Kanellias, Nikolaos, Dialoupi, Ioanna, Makris, Nikolaos, Manios, Efstathios, Migkou, Magdalini, Roussou, Maria, Kotsopoulou, Maria, Stellos, Konstantinos, Terpos, Evangelos, Trougakos, Ioannis P., Stamatelopoulos, Kimon, Dimopoulos, Meletios A.

Volltext

Current and novel BTK inhibitors in Waldenström’s macroglobulinemia von Ntanasis-Stathopoulos, Ioannis, Gavriatopoulou, Maria, Fotiou, Despina, Dimopoulos, Meletios A.

Volltext

Belantamab mafodotin, lenalidomide and dexamethasone in transplant-ineligible patients with newly diagnosed multiple myeloma: part 1 results of a phase I/II study von Terpos, Evangelos, Gavriatopoulou, Maria, Ntanasis-Stathopoulos, Ioannis, Malandrakis, Panagiotis, Fotiou, Despina, Migkou, Magdalini, Theodorakakou, Foteini, Spiliopoulou, Vasiliki, Kostopoulos, Ioannis V, Syrigou, Rodanthi-Eleni, Eleutherakis-Papaiakovou, Evangelos, Gkolfinopoulos, Stavros, Tsitsilonis, Ourania E, Kastritis, Efstathios, Dimopoulos, Meletios A

Volltext

Real-World Effectiveness and Safety of Belantamab Mafodotin Monotherapy in Triple-Class Refractory Multiple Myeloma von Ntanasis-Stathopoulos, Ioannis, Malandrakis, Panagiotis, Fotiou, Despina, Migkou, Magdalini, Theodorakakou, Foteini, Roussou, Maria, Eleutherakis-Papaiakovou, Evangelos, Spiliopoulou, Vassiliki, Kastritis, Efstathios, Terpos, Evangelos, Dimopoulos, Meletios-Athanasios, Gavriatopoulou, Maria

Volltext

Pomalidomide- and dexamethasone-based regimens in the treatment of refractory/relapsed multiple myeloma von Fotiou, Despina, Gavriatopoulou, Maria, Terpos, Evangelos, Dimopoulos, Meletios A.

Volltext

Monoclonal antibody-based therapies for Waldenström's macroglobulinemia von Fotiou, Despina, Theodorakakou, Foteini, Kastritis, Efstathios

Volltext

Use of Oral Antivirals Ritonavir-Nirmatrelvir and Molnupiravir in Patients with Multiple Myeloma Is Associated with Low Rates of Severe COVID-19: A Single-Center, Prospective Study von Spiliopoulou, Vassiliki, Ntanasis-Stathopoulos, Ioannis, Malandrakis, Panagiotis, Gavriatopoulou, Maria, Theodorakakou, Foteini, Fotiou, Despina, Migkou, Magdalini, Roussou, Maria, Eleutherakis-Papaiakovou, Evangelos, Kastritis, Efstathios, Dimopoulos, Meletios A, Terpos, Evangelos

Volltext

Clinical characteristics and outcomes of oligosecretory and non-secretory multiple myeloma von Migkou, Magdalini, Avivi, Irit, Gavriatopoulou, Maria, Cohen, Yael C., Fotiou, Despina, Kanellias, Nikolaos, Ziogas, Dimitrios, Eleutherakis-Papaiakovou, Evangelos, Terpos, Evangelos, Roussou, Maria, Kastritis, Efstathios, Dimopoulos, Meletios A.

Volltext

Carfilzomib-associated renal toxicity is common and unpredictable: a comprehensive analysis of 114 multiple myeloma patients von Fotiou, Despina, Roussou, Maria, Gakiopoulou, Charikleia, Psimenou, Erasmia, Gavriatopoulou, Maria, Migkou, Magdalini, Kanellias, Nikolaos, Dialoupi, Ioanna, Eleutherakis-Papaiakovou, Evangelos, Giannouli, Stavroula, Delavinia, Christina, Efstathiou, Kostantinos, Kontogiannis, Sofoklis, Terpos, Evangelos, Dimopoulos, Meletios A., Kastritis, Efstathios

Volltext

Long PFS of more than 7 years is achieved in 9% of myeloma patients in the era of conventional chemotherapy and of first-generation novel anti-myeloma agents: a single-center exper... von Terpos, Evangelos, Ntanasis-Stathopoulos, Ioannis, Roussou, Maria, Kanellias, Nikolaos, Fotiou, Despina, Migkou, Magdalini, Eleutherakis-Papaiakovou, Evangelos, Gavriatopoulou, Maria, Kastritis, Efstathios, Dimopoulos, Meletios A.

Volltext

Mutations in the alternative complement pathway in multiple myeloma patients with carfilzomib-induced thrombotic microangiopathy von Moscvin, Maria, Liacos, Christine Ivy, Chen, Tianzeng, Theodorakakou, Foteini, Fotiou, Despina, Hossain, Shahrier, Rowell, Sean, Leblebjian, Houry, Regan, Eileen, Czarnecki, Peter, Bagnoli, Filippo, Bolli, Niccolo’, Richardson, Paul, Rennke, Helmut G., Dimopoulos, Meletios A., Kastritis, Efstathios, Bianchi, Giada

Volltext

Cardiac and renal complications of carfilzomib in patients with multiple myeloma von Dimopoulos, Meletios A., Roussou, Maria, Gavriatopoulou, Maria, Psimenou, Erasmia, Ziogas, Dimitrios, Eleutherakis-Papaiakovou, Evangelos, Fotiou, Despina, Migkou, Magdalini, Kanellias, Nikolaos, Panagiotidis, Ioannis, Ntalianis, Argyrios, Papadopoulou, Elektra, Stamatelopoulos, Kimon, Manios, Efstathios, Pamboukas, Constantinos, Kontogiannis, Sofoklis, Terpos, Evangelos, Kastritis, Efstathios

Volltext

Future Developments in the Treatment of AL Amyloidosis von Theodorakakou, Foteini, Fotiou, Despina, Dimopoulos, Meletios A., Kastritis, Efstathios

Volltext

De Novo AL Amyloidosis in Renal Allograft and Anti‐CD38 Monoclonal Antibody Treatment von Fotiou, Despina, Skalioti, Chrysanthi, Liapis, George, Marinaki, Smaragdi, Kastritis, Efstathios

Volltext